触及Break-Even,乐普生物爆发期将至

明大教主
Aug 25

2025是创新药“大年”,至8月20日收盘,中证香港创新药指数年内上涨107.12%!我惊喜地发现,中证香港创新药指数涨幅TOP 5的成分股中,有3只是我的持仓。其中经常给大家科普的乐普生物以244.66%的涨幅排在该指数37个成分股的第三位。乐普生物属于经营脚踏实地,技术、管线壁垒均较强的企业。或许乐普生物在财经论坛的热度不及一些明星药企,但“是金子总会发光的”,今年终于轮到乐普生物市值、业绩双...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10